U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Transdermal drug delivery system

Patent 4687481 Issued on August 18, 1987. Estimated Expiration Date: Icon_subject March 3, 2006. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.

Patent References

2561071

Drug delivery device
Patent #: 3964482
Issued on: 06/22/1976
Inventor: Gerstel ,   et al.

Medical bandage
Patent #: 3996934
Issued on: 12/14/1976
Inventor: Zaffaroni

Polymeric diffusion matrix containing a vasodilator
Patent #: 4291015
Issued on: 09/22/1981
Inventor: Keith ,   et al.

Composite core coated microparticles and process of preparing same
Patent #: 4568559
Issued on: 02/04/1986
Inventor: Nuwayser ,   et al.

Drug delivery device Patent #: 4592753
Issued on: 06/03/1986
Inventor: Panoz

Inventor

Application

No. 06/835154 filed on 03/03/1986

US Classes:

424/449Transdermal or percutaneous

Examiners

Primary: Silverberg, Sam

Attorney, Agent or Firm

International Class

A61K 9/70 (20060101)

Abstract

A transdermal drug delivery system useful for the controlled, for example zero order release of one or more drugs to a selected skin area of a user, which system comprises an impervious backing sheet and a face membrane, the backing sheet and membrane secured together to form an intermediate reservoir. The face membrane is a macroporous membrane which has pores of sufficient size to avoid any rate control of the drug to be transdermally delivered to the user. The reservoir contains a viscous liquid base material selected to exude from the membrane to form a film and to occlude the skin of the user to force hydration of the stratum corneum with water from the lower layers of the epidermis of the user and a plurality of solid microparticles generally uniformly dispersed and suspended in the liquid base material. The microparticles containing an effective therapeutic amount of the drug for transdermal delivery, such as the contraceptive steroid. In use the liquid base material exuded from the macroporous membrane face forms a thermodynamically stable thin film layer in an intimate contact with the skin, while the drug is released from the microparticles into the base material and transdermally into the user.

PatentsPlus Images
Enhanced PDF formats
loading...
PatentsPlus: add to cart
PatentsPlus: add to cartSearch-enhanced full patent PDF image
$9.95more info
PatentsPlus: add to cart
PatentsPlus: add to cartIntelligent turbocharged patent PDFs with marked up images
$16.95more info
 
Sign InRegister
Username  
Password   
forgot password?